Article
Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Oct 2007
Shen Lanlan, Catalano Paul J, Benson Al B, O'Dwyer Peter, Hamilton Stanley R, Issa Jean-Pierre J
Abstract excerpt
PURPOSE: There are no good genomic markers of survival in patients with advanced colorectal cancer. The CpG island methylator phenotype (CIMP) marks a distinctive pathway in colorectal cancer. We sought to determine the prognostic significance of CIMP in advanced colorectal cancer patients treated with 5-fluorouracil (5-FU) in an Eastern Cooperative Oncology Group clinical trial. EXPERIMENTAL DESIGN: We studied...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
